MANILA, Philippines — The Philippines’ ongoing shift to green energy sources is leaving a trail of displaced indigenous communities and devastated land, and lost lives, watchdog Global Witness ...

These weight loss drugs are expensive out of pocket, though. Even with insurance, high co-pays can also limit who has access ...

With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy ...

THE Philippines finds itself at a pivotal juncture as it grapples with issues that challenge its political, economic and social stability. From unfulfilled campaign promises to questionable governance ...

For the uninitiated, both Zepbound (tirzepatide) and Wegovy (semaglutide) are weight loss drugs. They target hormones that ...

Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...

The demand for GLP-1 drugs (like Wegovy and several others) continues to grow. Despite this escalating demand, the prices for ...

If you want to take Wegovy, a glucagon-like peptide-1 (GLP-1 ... no additional consultation fee (included in total program cost) higher price point compared with similiar platforms requires ...

The trial, known as SURMOUNT-5, found that participants using Zepbound lost an average of 20.2% of their body weight, while those on Wegovy lost 13.7%. This marks a 47% difference in weight loss ...